Dr. Jerry Shapiro to Present RepliCel Data to European Academy of Dermatology and Venereology in Poland.
VANCOUVER, BC - May 23, 2013 - RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF) (CDNX: RP) reports that one of its founders, Dr. Jerry Shapiro, MD, FRCPC, will be presenting RepliCel's Phase I safety data and the concept of using dermal sheath cup cells for hair growth at the 10th European Academy of Dermatology and Venereology (EADV) Spring Symposium in Cracow, Poland on May 25th at 12:00 PM local time. The focus of the conference is on the "burden of skin disease".
"The RepliCel data from its RCH-01 Phase I trial treating pattern baldness is very promising," commented Dr. Shapiro, one of RepliCel's founders. "The trial provided the Company with safety and early efficacy data supporting a progression to the next phase. RepliCel's proposed Phase II dose-ranging study is designed to confirm the efficacy of injections of RCH-01 in over 100 male participants and will provide over 288 data points as compared to 16 in the Phase I trial. The Phase II trial should determine what the optimum dose is to promote hair growth," concluded Dr. Shapiro.
About Dr. Jerry Shapiro
Dr. Shapiro is one of the most experienced hair dermatologists in the world and has specialized in hair disorders for the past 22 years. He holds dual academic appointments as Clinical Professor and Adjunct Professor at both the University of British Columbia and New York University School of Medicine. Dr. Shapiro is the founder of the first comprehensive integrated medical and surgical hair clinic in the world. He has trained over thirty international hair fellows from four continents. He has published over 100 peer-reviewed papers, 15 book chapters and two books. He has lectured internationally on hair related topics on 173 occasions on 6 continents.
05-23-2013 09:58 AM
UK_
Better than Aderans who seem dead?
Only thing is, Dr David Hall said a year ago could look at 2015 release but their timeline states that in 2015 Phase 2 will only be finished - so once again (as has been happening consistently for the past 30 years), the "5 year" mark is being pushed back.
Now we're looking at 2017, I remember 3 years ago it was the same story with 2015, no doubt in 24 months the buzz-year on release will be '2020' and so on and so on.
05-23-2013 11:11 AM
JulioGP
Quote:
Originally Posted by UK_
Better than Aderans who seem dead?
Only thing is, Dr David Hall said a year ago could look at 2015 release but their timeline states that in 2015 Phase 2 will only be finished - so once again (as has been happening consistently for the past 30 years), the "5 year" mark is being pushed back.
Now we're looking at 2017, I remember 3 years ago it was the same story with 2015, no doubt in 24 months the buzz-year on release will be '2020' and so on and so on.
Do not be so pessimistic about that. Not everything happens in time we would like. These schedules are altered, as it is not child's play and are being invested millions of dollars that can not be thrown away.
It is normal to happen this kind of delay particularly when working with clinical trials. See AIDS or cancer occurs in the same away despite the focus here is the recovery of hair instead of diseases that lead to death.
05-23-2013 01:35 PM
Thinning87
is phase 2 confirmed for the second part of 2013, or are they still looking for investors to sponsor it?
05-24-2013 01:16 AM
UK_
Quote:
Originally Posted by Thinning87
is phase 2 confirmed for the second part of 2013, or are they still looking for investors to sponsor it?
Phase 2 is confirmed, btw, for those that know about Replicel, they wont suffer in finding investors lol.
05-24-2013 01:19 PM
Arashi
Quote:
Originally Posted by Thinning87
is phase 2 confirmed for the second part of 2013, or are they still looking for investors to sponsor it?
They just closed a private placement for CAD$509,502 last month. They'll probably do the same again in the (near) future.
05-24-2013 01:36 PM
Thinning87
Quote:
Originally Posted by Arashi
They just closed a private placement for CAD$509,502 last month. They'll probably do the same again in the (near) future.
and that is enough to go into phase 2? That's nothing!
05-24-2013 01:48 PM
Arashi
Quote:
Originally Posted by Thinning87
and that is enough to go into phase 2? That's nothing!
That's why I added "They'll probably do the same again in the (near) future". But do keep in mind phase II is generally way cheaper than phase III.
05-24-2013 01:54 PM
eqvist
Quote:
Originally Posted by Arashi
That's why I added "They'll probably do the same again in the (near) future". But do keep in mind phase II is generally way cheaper than phase III.
Okey that i didnīt know. Why is phase 2 cheaper?
05-24-2013 02:15 PM
garethbale
Quote:
Originally Posted by eqvist
Okey that i didn´t know. Why is phase 2 cheaper?
More number of test subjects is the main reason I think, Phase 2 is usually a few dozen subjects, phase 3 a few hundred
